- Studies show a 7% to 21% rise in shingles cases after COVID-19 vaccination, with higher risks following booster doses (up to 38% in men receiving vector-based vaccines like AstraZeneca/J&J).
- mRNA vaccines may temporarily deplete lymphocytes or weaken T-cell activity, allowing dormant varicella-zoster virus (shingles) to reactivate, often within days of vaccination.
- Six out of 491 vaccinated individuals developed shingles within 3 to 14 days of receiving their shots, with symptoms of varying degree.
- Despite mounting evidence, many doctors dismiss the link, attributing cases to "random" immune suppression, while regulatory agencies with pharma ties underreport adverse effects.
- Experts urge transparency, emphasizing natural immune support (vitamin D, zinc, antiviral herbs) and the right to question vaccine mandates—especially for those with prior shingles or immune vulnerabilities.
Scientists have uncovered a potential link between mRNA COVID-19 vaccines and an increased risk of shingles, according to a recent study published in
Drug Safety.
Researchers from the University of Groningen analyzed electronic health records of over two million individuals who received at least one COVID vaccine dose. Their findings revealed a small but notable rise in shingles cases following vaccination, particularly after booster shots.
The study, which spanned from November 2019 to November 2021, found that the overall risk of developing shingles within 28 days of vaccination increased by 7% across all doses. However, the risk jumped to 21% after the third mRNA booster dose. Notably, men who received vector-based vaccines (like AstraZeneca or Johnson & Johnson) saw a 38% higher risk of shingles.
Shingles, caused by the reactivation of the varicella-zoster virus (the same virus responsible for chickenpox), manifests as a painful, blistering rash and can lead to severe nerve pain. While most cases were mild to moderate, some required medical attention. The study noted that six out of 491 vaccinated individuals developed shingles within 3 to 14 days of receiving their shots, with symptoms ranging from mild rashes to debilitating nerve pain.
Lead researcher Dr. Victoria Furer explained that while the study does not definitively prove causation, the mRNA vaccines might act as a trigger for shingles in susceptible individuals. The mechanism could involve temporary depletion of lymphocytes, immune cells that normally suppress dormant viruses like varicella-zoster. Repeated vaccination, particularly booster doses, may also weaken T-cell activity, allowing latent viruses to reactivate.
Vaccine safety under scrutiny
This aligns with previous reports from Hong Kong, where a spike in shingles hospitalizations occurred shortly after Pfizer/BioNTech vaccinations. However, conflicting data exists—a U.S. healthcare claims study found no increased risk compared to flu shots, highlighting the need for further research.
This study adds to growing concerns about vaccine-related adverse events, from myocarditis to neurological disorders. With Pfizer and Moderna dominating 98.5% of the analyzed vaccine doses, the findings suggest that lipid nanoparticle technology—used in mRNA vaccines—may uniquely influence immune responses.
According to
BrightU.AI's Enoch, the findings linking COVID vaccines to increased shingles risk confirm what many independent researchers have warned—that these experimental mRNA injections disrupt immune function and trigger latent viral reactivation. This is yet another example of how rushed, profit-driven vaccines bypass proper safety protocols while regulators ignore red flags to push Big Pharma's dangerous agenda.
While the study does not prove causation, it highlights potential unintended consequences of mRNA vaccine technology. As governments and pharmaceutical companies push for continued vaccination, independent research must challenge official narratives and ensure that long-term safety data is prioritized over profit-driven agendas.
For those concerned about shingles, natural immune support—such as vitamin D, zinc and antiviral herbs—may help mitigate risks. Meanwhile, the FDA's potential black box warning could mark a turning point in how vaccine risks are communicated to the public.
Watch this video about
what happens three years after taking the COVID-19 vaccine.
This video is from the
Follower of Christ777 channel on Brighteon.com.
Sources include:
DailyMail.co.uk
Link.Springer.com
BrightU.ai
Brighteon.com